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We have known for over a decade that critical illness survivors suffer from significant functional disability after hospital
discharge. Muscle wasting is a major contributor to this disability, occurring early and rapidly during critical illness, with
the subsequent weakness associated with delayed weaning and prolonged hospital stay. The scale of this long-term
public health issue is concerning for two important reasons: increasing numbers of patients survive critical illness, and
this is compounded by the lack of interventions to reduce skeletal muscle wasting to combat the functional disability.
In the current issue of Critical Care, Weijs and colleagues demonstrate an indirect relationship between skeletal muscle
mass on admission to the ICU and mortality. Observational data were obtained from 240 critically ill patients, all of
whom received abdominal computer tomography scans for clinical reasons. Skeletal muscle volume was calculated for
all visible skeletal muscle at the level of the third lumbar vertebra. In both continuous and categorical regression
analysis, lower muscle volume on admission was associated with higher mortality, independent of Acute Physiology
and Chronic Health Evaluation II score and gender. Interestingly, no association was observed between mortality and
body mass index. These data also demonstrate that more than twice as many critical illness survivors with a low muscle
mass on admission, compared to those with preserved muscle mass, were discharged to a nursing home. While this
approach is novel and the results support the current clinical view in this area, one must regard these data with
caution. Clinically relevant details, such as prior functional status, are not available. Despite these caveats, this study has
two main messages. Firstly, muscle mass on admission to the ICU is a predictor of mortality and this physiological
biomarker should therefore strongly be considered as an outcome measure in interventional studies. Secondly, low
admission muscle mass is associated with increased disability and, in the case of this study, associated with an
increased frequency of discharge to nursing homes. Further investigation is required to demonstrate the relationship
between muscle mass, functional ability and discharge location.In the current issue of Critical Care, Weijs and colleagues
[1] demonstrate an indirect relationship between skeletal
muscle mass on admission to the ICU and mortality. We
have known for over a decade that critical illness survivors
suffer from significant functional disability after hospital
discharge [2]. Muscle wasting is a major contributor to
this disability, occurring early and rapidly during critical
illness [3], with the subsequent weakness associated with
delayed weaning and prolonged hospital stay [4]. The scale* Correspondence: Zudin_amilka_puthucheary@nuhs.edu.sg
1Institute of Health and Human Performance, University College London,
Gower Street, London WC1E 6BT, UK
2Division of Respiratory and Critical Care Medicine, University Medicine
Cluster, National University Health System, 5 Lower Kent Ridge Road, 119074
Singapore, Singapore
Full list of author information is available at the end of the article
© Puthucheary and Hart; licensee BioMe
medium, for 12 months following its publicat
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
2014of this long-term public health issue is concerning for two
important reasons: increasing numbers of patients survive
critical illness, and this is compounded by the lack of in-
terventions to reduce skeletal muscle wasting to combat
the functional disability [5].
Although early exercise-based interventions have shown
clinical benefit in terms of functional outcome [6], this
effect is by no means universal across different healthcare
models [7-9]. A recent trial that focused on the continuum
of rehabilitation from admission through to post-hospital
discharge failed to demonstrate a functional outcomes
benefit [8]. In addition to these disappointing results in
terms of rehabilitation delivery, data are currently lacking,
based on recent trials [10,11], to guide timing and quantity
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suggest that high protein delivery may have an adverse im-
pact on muscle protein synthesis during the first week of
critical illness [3].
Weijs and colleagues obtained observational data from
240 critically ill patients, all of whom received abdominal
computer tomography scans for clinical reasons, and
calculated skeletal muscle volume of all visible skeletal
muscles at the level of the third lumbar vertebra. In both
continuous and categorical regression analysis, lower
muscle volume on admission was associated with higher
mortality, which was independent of Acute Physiology
and Chronic Health Evaluation (APACHE) II score and
gender. Interestingly, no association was observed be-
tween mortality and body mass index.
While this approach is novel and the results support the
current clinical view in this area, one must regard these
data with caution, which the authors also acknowledge.
Despite the higher mortality being independent of APA-
CHE II and gender, these rather blunt descriptors of
patient demographics do not detail the differing admission
diagnoses, with multiple chronic diseases observed in
those patients with lower muscle mass; these details are
absent from this retrospective study. These data also dem-
onstrated that more than twice as many critical illness sur-
vivors with a low muscle mass on admission, compared to
those with preserved muscle mass, were discharged to a
nursing home. Unfortunately, clinically relevant details
such as prior functional status are not available.
Despite these caveats, this study has two main messages.
Firstly, muscle mass on admission to the ICU is a predictor
of mortality and should therefore strongly be considered
as an outcome measure in interventional studies. Secondly,
low admission muscle mass is associated with increased
disability and, in the case of this study, with an increased
frequency of discharge to a nursing home. Further investi-
gation is required to demonstrate the relationship between
muscle mass, functional ability and discharge location.
However, the unanswered question is whether the change
in muscle mass admission or the absolute muscle mass on
admission is the most important predictor of outcome.
This may in fact be relevant to all hospitalized patients
rather than just the critically ill.
Whilst muscle wasting occurs early and rapidly during
the first week after admission [3], it may be that baseline
muscle mass has a greater influence on subsequent func-
tional ability and, as in this retrospective study, overall
mortality. Indeed, low muscle mass has been noted as an
independent predictor of mortality in chronic ambulant
diseases such as chronic obstructive pulmonary disease,
congestive cardiac failure and end-stage renal failure [13].
In the elderly, increased mortality has been observed in
patients with age-related muscle loss, so called sarcopenia,
and in those considered to be functionally disabled as aresult of clinical frailty [14]. Despite this, baseline muscle
mass has no relationship with muscle wasting per se [3],
and there have been no studies adjusting for this, particu-
larly in those focused on functional outcome. Such data
are necessary so that we can provide evidence demonstrat-
ing the clinical benefit of rehabilitation [7]. For muscle
mass on admission to ICU to be used as part of a clinical
practice algorithm in prognostication, multicentre obser-
vational prospective studies are essential.
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